71 related articles for article (PubMed ID: 24300528)
1. An evaluation of the morphologic features of low-grade mucinous neoplasms of the appendix metastatic in the ovary, and comparison with primary ovarian mucinous tumors.
Stewart CJ; Ardakani NM; Doherty DA; Young RH
Int J Gynecol Pathol; 2014 Jan; 33(1):1-10. PubMed ID: 24300528
[TBL] [Abstract][Full Text] [Related]
2. Does a Positive Appendiceal Resection Margin in Low-Grade Appendiceal Mucinous Neoplasms, Warrant Additional Surgery? Our Institution Experience and Literature Review.
Ibrahim E; Akrmah M; Ligato S
Ann Surg Oncol; 2023 Nov; 30(12):7189-7195. PubMed ID: 37477747
[TBL] [Abstract][Full Text] [Related]
3. A Novel Assessment of Metabolic Pathways in Peritoneal Metastases from Low-Grade Appendiceal Mucinous Neoplasms.
Hanse EA; Wang T; Tifrea D; Senthil M; Kim AC; Kong M; Eng OS
Ann Surg Oncol; 2023 Aug; 30(8):5132-5141. PubMed ID: 37149550
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasonography findings of LAMNs with peritoneal and splenic metastases: a case report and literature review.
Chen M; Zhang S; Xu Y; Jia X; Shi Y
Front Oncol; 2023; 13():1238042. PubMed ID: 37817772
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
Strickland S; Parra-Herran C
Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
[TBL] [Abstract][Full Text] [Related]
6. Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature.
Kleppe M; Bruls J; Van Gorp T; Massuger L; Slangen BF; Van de Vijver KK; Kruse AJ; Kruitwagen RF
Gynecol Oncol; 2014 May; 133(2):155-8. PubMed ID: 24552756
[TBL] [Abstract][Full Text] [Related]
7. Republished: mucinous tumours of appendix and ovary: an overview and evaluation of current practice.
Rouzbahman M; Chetty R
Postgrad Med J; 2015 Jan; 91(1071):41-5. PubMed ID: 25583738
[TBL] [Abstract][Full Text] [Related]
8. Ovarian mucinous tumors arising from mature cystic teratomas--a molecular genetic approach for understanding the cellular origin.
Fujii K; Yamashita Y; Yamamoto T; Takahashi K; Hashimoto K; Miyata T; Kawai K; Kikkawa F; Toyokuni S; Nagasaka T
Hum Pathol; 2014 Apr; 45(4):717-24. PubMed ID: 24485845
[TBL] [Abstract][Full Text] [Related]
9. Appendiceal mucinous neoplasm mimics ovarian tumors: Challenges for preoperative and intraoperative diagnosis and clinical implication.
Zhang W; Tan C; Xu M; Wu X
Eur J Surg Oncol; 2019 Nov; 45(11):2120-2125. PubMed ID: 31462390
[TBL] [Abstract][Full Text] [Related]
10. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases.
Schmoeckel E; Kirchner T; Mayr D
Pathol Res Pract; 2018 Mar; 214(3):426-430. PubMed ID: 29487003
[TBL] [Abstract][Full Text] [Related]
11. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.
Carr NJ; Cecil TD; Mohamed F; Sobin LH; Sugarbaker PH; González-Moreno S; Taflampas P; Chapman S; Moran BJ;
Am J Surg Pathol; 2016 Jan; 40(1):14-26. PubMed ID: 26492181
[TBL] [Abstract][Full Text] [Related]
12. [Mucinous tumors of the peritoneum].
Fischer AK; Tannapfel A; Quaas A
Chirurgie (Heidelb); 2023 Oct; 94(10):823-831. PubMed ID: 37418023
[TBL] [Abstract][Full Text] [Related]
13. Misdiagnosed appendiceal mucinous neoplasms and primary ovarian mucinous tumors present with different pre- and intraoperative characteristics.
Yu Y; Wang T; Yuan Z; Lin W; Yang J; Cao D
Front Oncol; 2022; 12():966844. PubMed ID: 36091177
[TBL] [Abstract][Full Text] [Related]
14. A case of Pseudomyxoma Peritonei of an unexpected origin.
Csanyi-Bastien M; Blanchard F; Lamy A; Sabourin JC
Diagn Pathol; 2021 Dec; 16(1):119. PubMed ID: 34930348
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Characteristics and Prognostic Prediction in Pseudomyxoma Peritonei Originating From Mucinous Ovarian Cancer.
Fu F; Ma X; Lu Y; Xu H; Ma R
Front Oncol; 2021; 11():641053. PubMed ID: 33968739
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Characteristics of Pseudomyxoma Peritonei Originated from Ovaries.
Yan F; Shi F; Li X; Yu C; Lin Y; Li Y; Jin M
Cancer Manag Res; 2020; 12():7569-7578. PubMed ID: 32904568
[TBL] [Abstract][Full Text] [Related]
17. Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens-A review and evidence-based guide.
Bhatt A; Mishra S; Parikh L; Sheth S; Gorur I
Indian J Surg Oncol; 2020 Mar; 11(1):101-126. PubMed ID: 32205979
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative consultation for ovarian tumors.
Kim I
Yeungnam Univ J Med; 2019 Sep; 36(3):163-182. PubMed ID: 31620631
[TBL] [Abstract][Full Text] [Related]
19. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.
Meagher NS; Wang L; Rambau PF; Intermaggio MP; Huntsman DG; Wilkens LR; El-Bahrawy MA; Ness RB; Odunsi K; Steed H; Herpel E; Anglesio MS; Zhang B; Lambie N; Swerdlow AJ; Lubiński J; Vierkant RA; Goode EL; Menon U; Toloczko-Grabarek A; Oszurek O; Bilic S; Talhouk A; García-Closas M; Wang Q; Tan A; Farrell R; Kennedy CJ; Jimenez-Linan M; Sundfeldt K; Etter JL; Menkiszak J; Goodman MT; Klonowski P; Leung Y; Winham SJ; Moysich KB; Behrens S; Kluz T; Edwards RP; Gronwald J; Modugno F; Hernandez BY; Chow C; Kelemen LE; Keeney GL; Carney ME; Natanzon Y; Robertson G; Sharma R; Gayther SA; Alsop J; Luk H; Karpinskyj C; Campbell I; Sinn P; Gentry-Maharaj A; Coulson P; Chang-Claude J; Shah M; Widschwendter M; Tang K; Schoemaker MJ; Koziak JM; Cook LS; Brenton JD; Daley F; Kristjansdottir B; Mateoiu C; Larson MC; Harnett PR; Jung A; deFazio A; Gorringe KL; Pharoah PDP; Minoo P; Stewart C; Bathe OF; Gui X; Cohen P; Ramus SJ; Köbel M
Mod Pathol; 2019 Dec; 32(12):1834-1846. PubMed ID: 31239549
[TBL] [Abstract][Full Text] [Related]
20. Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.
Hotta M; Minamimoto R; Gohda Y; Igari T; Yano H
Eur Radiol; 2019 Oct; 29(10):5709-5716. PubMed ID: 30874878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
